NAD+ red blood cell
Selected indexed studies
- Methaemoglobinaemia. (Clin Haematol, 1981) [PMID:7011627]
- NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis. (Blood, 2025) [PMID:41100733]
- Red blood cell oxidative metabolism induced by hydroxypyruvaldehyde. (Biochem Pharmacol, 1985) [PMID:3994738]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Methaemoglobinaemia. (1981) pubmed
- NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis. (2025) pubmed
- Red blood cell oxidative metabolism induced by hydroxypyruvaldehyde. (1985) pubmed
- Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis. (2002) pubmed
- Cytosolic phosphorylation potential. (1979) pubmed
- Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential. (1998) pubmed
- Metabolic dependence of red cell deformability. (1969) pubmed
- Red-cell glucose metabolism. (1971) pubmed
- Disorders due to enzyme defects in the red blood cell. (1972) pubmed
- Assessment of NAD(+)metabolism in human cell cultures, erythrocytes, cerebrospinal fluid and primate skeletal muscle. (2019) pubmed